Search for: "KV Pharmaceuticals"
Results 81 - 92
of 92
Sort by Relevance
|
Sort by Date
2 Aug 2008, 12:54 am
, (Daily Dose of IP), 20 August – Bill Patry Copyright Blog speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry Copyright Blog speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry Copyright Blog speaking on copyright – Sydney: (Patry Copyright Blog), (LawFont.com), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat),… [read post]
31 Jul 2008, 9:44 pm
What do we know about KV Pharmaceutical? [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
23 Jun 2008, 2:54 am
KV Pharmaceutical Co. 3:08-cv-03012; filed June 17, 2008 in the District Court of New Jersey Infringement of U.S. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
27 Apr 2008, 9:40 pm
KV Pharmaceutical Co. 1:08-cv-00223; filed April 18, 2008 in the District Court of Delaware... [read post]
6 Aug 2007, 4:37 am
Patent No. 5,001,161, entitled "Pharmaceutical composition comprising metroprolol succinate," and U.S. [read post]
25 Jul 2007, 8:10 pm
KV Pharmaceutical, Andrx, and Eon Labs have all filed ANDAs for generic Toprol-XL and are defendants in the litigation. [read post]
23 Jul 2007, 4:04 pm
KV Pharmaceutical Co.), No. 06-1254 (Fed. [read post]
5 Nov 2006, 8:29 pm
KV Pharmaceutical Uniretic--Schwarz Pharma v. [read post]
29 Oct 2006, 7:43 pm
Harper KV Pharmaceutical Company recently filed a citizen petition asking the FDA to relist U.S. [read post]
